Glenmark Pharmaceuticals.
Indian multinational pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 33
What's happening
One to three months ago
-
Glenmark Pharmaceuticals launched a product in Brazil after receiving regulatory approval from ANVISA, also noting US approval.Some support3 reports
-
Glenmark Pharmaceuticals and South Piedmont Community College announced a partnership focusing on pharmaceutical manufacturing workforce development in North Carolina.Some support1 report
-
Stock targets indicate strong buying trend for Laurus Labs and Glenmark Pharmaceuticals.Some support1 report
-
Glenmark Pharmaceuticals is seeking marketing authorization for its products in key European markets.Some support1 report1 development inside
-
Glenmark launched an equivalent drug to Merck's BRIDION.Some support2 reports
Gone quiet
No new reports in 90+ days-
Glenmark Pharmaceuticals is being investigated for allegedly conspiring with competitors, including Apotex, to fix generic drug prices.Some support1 report
-
The European Commission granted marketing authorization for Winlevi, a product manufactured by Glenmark Pharmaceuticals, on June 1, 2026.Some support1 report
-
AbbVie and Glenmark Pharmaceuticals are noted as leading players in the nocturia market, driven by geriatric population shifts.Speculative1 report
No events began in the chosen period. Widen it, or reset.
Around Glenmark Pharmaceuticals this week
News at the entities that move Glenmark Pharmaceuticals most-
European Commission StructuralMark Carney visited Ireland to push negotiations for a digital trade agreement and suggested Canada become an EU associate member.Moves Glenmark Pharmaceuticals
-
North Carolina StructuralAn illegal alien from El Salvador was arrested in North Carolina, while Markwayne Mullin alerted several states about voter rolls.Moves Glenmark Pharmaceuticals
-
FDA StructuralThe FDA approved Edwards' PASCAL Precision system, which is the sole provider of these therapies in the US.Moves Glenmark Pharmaceuticals
-
Merck Sharp & Dohme OperationalEvaxion will present clinical trial data at the ESMO Congress 2025 in Berlin, utilizing therapy from Merck Sharp & Dohme.Moves Glenmark Pharmaceuticals
-
company StructuralGLM, a company operating in Vancouver, BC, uses its proprietary technology to support patients on Medicare.Moves Glenmark Pharmaceuticals
-
North America Shared contextHSG Laser is highlighting continued investment in the North American market and has established a Technical & Solution Center in Illinois.Moves Glenmark Pharmaceuticals
Connections
The 12 strongest of 33, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
company Structural
Glenmark Pharmaceuticals is the parent company of the entity known as 'company', which operates as a wholly-owned subsidiary.
-
European Commission Structural
Glenmark seeks market authorization from the European Commission for product launch.
-
North Carolina Structural
North Carolina is investigating Glenmark Pharmaceuticals regarding generic drug price-fixing, while the company operates a manufacturing facility in the state.
-
Merck Sharp & Dohme Operational
The two companies are in direct market competition, evidenced by Glenmark launching a drug equivalent to Merck's BRIDION.
-
FDA Structural
The FDA acts as the formal regulatory body responsible for approving products relevant to Glenmark Pharmaceuticals.
-
Brazilian Health Regulatory Agency Structural
The company operates under the formal oversight and product approval requirements of the Brazilian health regulatory agency.
-
Apotex Operational
Apotex and Glenmark Pharmaceuticals are alleged to have conspired to fix prices with competitors.
-
South Piedmont Community College Operational
Glenmark Pharmaceuticals and South Piedmont Community College maintain a partnership focused on pharmaceutical manufacturing workforce development.
Show all 12 connections
-
North America Shared context
Glenmark Pharmaceuticals operates and launches products within the North American market.
-
Mumbai Shared context
Glenmark Pharmaceuticals utilizes Mumbai as a location for industry symposiums and events.
-
Europe Shared context
Glenmark Pharmaceuticals is actively launching products within key European markets.
-
Donald Trump Shared context
The relationship is contextual, as proposed tariffs associated with Donald Trump are noted to affect the generic drug manufacturing sector.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
1 eventJuly 2026
2 eventsShow 1 earlier month
June 2026
3 events- Glenmark Pharmaceuticals is seeking marketing authorization for its products in key European markets.
- The European Commission granted marketing authorization for Winlevi, a product manufactured by Glenmark Pharmaceuticals, on June 1, 2026.
- AbbVie and Glenmark Pharmaceuticals are noted as leading players in the nocturia market, driven by geriatric population shifts.